Evaluating Patient Experiences in Dry Eye Disease Through Social Media Listening Research.
Disease burden
Dry eye
Patients’ experiences
Quality of life
Social media
Twitter
Unmet needs
Journal
Ophthalmology and therapy
ISSN: 2193-8245
Titre abrégé: Ophthalmol Ther
Pays: England
ID NLM: 101634502
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
27
03
2019
pubmed:
5
6
2019
medline:
5
6
2019
entrez:
5
6
2019
Statut:
ppublish
Résumé
Social media listening (SML) is an approach to assess patient experience in different indications. This is the first study to report the results of using SML to understand patients' experiences of living with dry eye disease (DED). Publicly available, English-language social media content between December 2016 and August 2017 was searched employing pre-defined criteria using Social Studio In all, 2279 possible patient records were identified following NLP, which were filtered for relevance to disease area by analysts, resulting in a total of 1192 posts which formed the basis of this study. Of these, 77% (n = 915) were from the USA. Symptoms, causes, diagnosis and treatments were the most commonly discussed themes. Most common symptoms mentioned were eye dryness (138/901), pain (114/901) and blurry vision (110/901). Pharmaceutical drugs (prescription and over-the-counter; 55%; 764/1393), followed by medical devices (20%; 280/1393), were mentioned as major options for managing symptoms. Of the pharmaceutical drugs, eye drops (33%; 158/476) and artificial tears (10%; 49/476) were the most common over-the-counter options reported, and Restasis Insights revealed using SML strengthen our understanding about patient experiences and their unmet needs in DED. This study illustrates that an SML approach contributed effectively in generating patient insights, which can be utilised to inform early drug development process, market access strategies and stakeholder discussions. Novartis Pharma AG, Basel, Switzerland. Plain language summary available for this article.
Identifiants
pubmed: 31161531
doi: 10.1007/s40123-019-0188-4
pii: 10.1007/s40123-019-0188-4
pmc: PMC6692792
doi:
Types de publication
Journal Article
Langues
eng
Pagination
407-420Références
Ophthalmology. 2003 Jul;110(7):1412-9
pubmed: 12867401
Prev Chronic Dis. 2005 Jan;2(1):A13
pubmed: 15670466
Cornea. 2005 Oct;24(7):804-10
pubmed: 16160496
Am J Ophthalmol. 2007 Mar;143(3):409-15
pubmed: 17317388
Cornea. 2011 Apr;30(4):379-87
pubmed: 21045640
Int J Technol Assess Health Care. 2011 Oct;27(4):376-83
pubmed: 22004780
Curr Ophthalmol Rep. 2013 Jun;1(2):51-57
pubmed: 23710423
Patient Educ Couns. 2013 Sep;92(3):426-31
pubmed: 23899831
Acta Ophthalmol. 2014 Mar;92(2):e124-32
pubmed: 23901943
PLoS One. 2013 Sep 30;8(9):e76121
pubmed: 24098772
J Med Internet Res. 2014 Jul 14;16(7):e171
pubmed: 25048247
Dtsch Arztebl Int. 2015 Jan 30;112(5):71-81; quiz 82
pubmed: 25686388
Cornea. 2015 May;34(5):500-5
pubmed: 25782401
BMC Pregnancy Childbirth. 2015 May 16;15:116
pubmed: 25982305
Sociol Health Illn. 2016 May;38(4):543-58
pubmed: 26564262
Ocul Surf. 2016 Apr;14(2):144-67
pubmed: 26733111
J Med Internet Res. 2016 Mar 17;18(3):e62
pubmed: 26987964
Ocul Surf. 2016 Jul;14(3):365-76
pubmed: 27224876
Invest Ophthalmol Vis Sci. 2016 Jun 1;57(7):2975-82
pubmed: 27273596
Ocul Surf. 2016 Oct;14(4):440-446
pubmed: 27395775
Br J Ophthalmol. 2017 Aug;101(8):1100-1105
pubmed: 28003235
Inflamm Bowel Dis. 2017 Jul;23(7):1057-1064
pubmed: 28410343
J Arthroplasty. 2017 Sep;32(9):2694-2700
pubmed: 28456560
J Med Internet Res. 2017 Jun 07;19(6):e200
pubmed: 28592395
JMIR Public Health Surveill. 2017 Jun 19;3(2):e38
pubmed: 28630032
Am J Ophthalmol. 2017 Oct;182:90-98
pubmed: 28705660
J Assoc Nurses AIDS Care. 2018 Jan - Feb;29(1):107-114
pubmed: 28709753
Ocul Surf. 2017 Oct;15(4):802-812
pubmed: 28797892